Moderna
MRNA
#1116
Rank
$20.14 B
Marketcap
$50.80
Share price
5.33%
Change (1 day)
79.19%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Earnings for Moderna (MRNA)

Earnings in 2025 (TTM): -$2.76 Billion USD

According to Moderna 's latest financial reports the company's current earnings are $1.92 Billion USD. , an increase over its 2024 earnings that were of -$3.59 Billion USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Moderna from 2018 to 2025

Annual earnings

Year Earnings Change
2025 -$2.76 Billion-23.03%
2024 -$3.59 Billion-8.22%
2023 -$3.91 Billion-140.65%
2022 $9.60 B-27.81%
2021 $13.30 B-1911.15%
2020 -$0.74 Billion44.7%
2019 -$0.51 Billion28.63%
2018 -$0.4 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
$33.55 B-1,316.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
$16.35 B-692.89%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
$22.42 B-913.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
-$47.43 Million-98.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-$0.12 Billion-95.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-$41.77 Million-98.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
$0.57 B-120.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
$0.34 B-112.51%๐Ÿ‡บ๐Ÿ‡ธ USA